Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
Advanced Parkinson's disease (APD) is characterized by increased functional disability, caused by motor complications, the presence of axial symptoms, and emergent disease- and drug-related non-motor symptoms. One of the advanced therapies available is intrajejunal infusion of levodopa/carbidop...
| Հիմնական հեղինակներ: | , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Elsevier
2017-09-01
|
| Շարք: | eNeurologicalSci |
| Առցանց հասանելիություն: | http://www.sciencedirect.com/science/article/pii/S2405650217300217 |